ES548008A0 - Procedimiento para preparar derivados de 4-alcoxi-pirido-(2,3-d)pirimidina - Google Patents
Procedimiento para preparar derivados de 4-alcoxi-pirido-(2,3-d)pirimidinaInfo
- Publication number
- ES548008A0 ES548008A0 ES548008A ES548008A ES548008A0 ES 548008 A0 ES548008 A0 ES 548008A0 ES 548008 A ES548008 A ES 548008A ES 548008 A ES548008 A ES 548008A ES 548008 A0 ES548008 A0 ES 548008A0
- Authority
- ES
- Spain
- Prior art keywords
- pirimidina
- pirido
- alcoxi
- procedure
- well
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19843438351 DE3438351A1 (de) | 1984-10-19 | 1984-10-19 | 4-alkoxy-pyrido(2,3-d)pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung |
Publications (2)
Publication Number | Publication Date |
---|---|
ES548008A0 true ES548008A0 (es) | 1986-03-16 |
ES8605519A1 ES8605519A1 (es) | 1986-03-16 |
Family
ID=6248308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES548008A Expired ES8605519A1 (es) | 1984-10-19 | 1985-10-18 | Procedimiento para preparar derivados de 4-alcoxi-pirido-(2,3-d)pirimidina |
Country Status (14)
Country | Link |
---|---|
US (2) | US4681882A (es) |
EP (1) | EP0180834B1 (es) |
JP (1) | JPS61100582A (es) |
CN (1) | CN1004274B (es) |
AT (1) | ATE45949T1 (es) |
AU (1) | AU579413B2 (es) |
CA (1) | CA1257261A (es) |
DD (1) | DD239794A5 (es) |
DE (2) | DE3438351A1 (es) |
DK (1) | DK478585A (es) |
ES (1) | ES8605519A1 (es) |
GR (1) | GR852529B (es) |
HU (1) | HU194227B (es) |
ZA (1) | ZA857989B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3438350A1 (de) * | 1984-10-19 | 1986-04-24 | Gödecke AG, 1000 Berlin | 4-oxo-pyrido (2,3-d) pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung |
DE3501696A1 (de) * | 1985-01-19 | 1986-07-24 | Bayer Ag, 5090 Leverkusen | Pyridopyrimidine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
US5059602A (en) * | 1990-08-27 | 1991-10-22 | Hoechst-Roussel Pharmaceuticals Inc. | 4-substituted dihydropyrido(4,3-d)pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders |
ATE445838T1 (de) | 2001-07-25 | 2009-10-15 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
EP2671508B1 (en) | 2005-04-28 | 2020-09-16 | Proteus Digital Health, Inc. | Pharma-informatics system |
DE102006026585A1 (de) * | 2006-06-07 | 2007-12-13 | Bayer Healthcare Aktiengesellschaft | Substituierte 4-Aryl-1,4-dihydro-1,6-naphthyridine und ihre Verwendung |
DE102006026583A1 (de) * | 2006-06-07 | 2007-12-13 | Bayer Healthcare Aktiengesellschaft | Aryl-substituierte hetero-bicyclische Verbindungen und ihre Verwendung |
CA2663377A1 (en) | 2006-09-18 | 2008-03-27 | Raptor Pharmaceutical Inc. | Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates |
HUE059078T2 (hu) | 2009-02-20 | 2022-10-28 | Enhanx Biopharm Inc | Glutation-alapú hatóanyagszállító rendszer |
JP2012526144A (ja) | 2009-05-06 | 2012-10-25 | ラボラトリー スキン ケア インコーポレイテッド | 活性物質−リン酸カルシウム粒子複合体を含む経皮送達組成物およびその使用方法 |
US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE525394A (es) * | ||||
US3673184A (en) * | 1970-09-02 | 1972-06-27 | Dainippon Pharmaceutical Co | Certain 2-substituted-5,8-dihydro-5-oxopyrido{8 2,3-d{9 pyrimidine-6-carboxylic acid derivatives |
US4271164A (en) * | 1979-04-16 | 1981-06-02 | Warner-Lambert Company | 6-Substituted-arylpyrido[2,3-d]pyrimidin-7-amines and derivatives |
US4361700A (en) * | 1980-05-20 | 1982-11-30 | James S. Waldron | Pyridopyrimidinone derivatives |
US4560753A (en) * | 1982-11-05 | 1985-12-24 | Sterling Drug Inc. | 2-Substituted-pyrido[2,3-d]pyrimidin-5(8H)-ones |
US4432981A (en) * | 1982-11-05 | 1984-02-21 | Sterling Drug Inc. | 2-(Pyridinyl or hydroxyphenyl)-8-substituted pyrido[2,3-d]pyrimidin-5(8H)-ones |
DE3438350A1 (de) * | 1984-10-19 | 1986-04-24 | Gödecke AG, 1000 Berlin | 4-oxo-pyrido (2,3-d) pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung |
-
1984
- 1984-10-19 DE DE19843438351 patent/DE3438351A1/de not_active Withdrawn
-
1985
- 1985-10-16 CN CN85107614.9A patent/CN1004274B/zh not_active Expired
- 1985-10-16 US US06/787,844 patent/US4681882A/en not_active Expired - Fee Related
- 1985-10-17 CA CA000493181A patent/CA1257261A/en not_active Expired
- 1985-10-17 JP JP60230048A patent/JPS61100582A/ja active Pending
- 1985-10-17 ZA ZA857989A patent/ZA857989B/xx unknown
- 1985-10-18 EP EP85113270A patent/EP0180834B1/de not_active Expired
- 1985-10-18 DK DK478585A patent/DK478585A/da not_active Application Discontinuation
- 1985-10-18 AT AT85113270T patent/ATE45949T1/de not_active IP Right Cessation
- 1985-10-18 ES ES548008A patent/ES8605519A1/es not_active Expired
- 1985-10-18 DE DE8585113270T patent/DE3572663D1/de not_active Expired
- 1985-10-18 GR GR852529A patent/GR852529B/el unknown
- 1985-10-18 HU HU854037A patent/HU194227B/hu unknown
- 1985-10-18 DD DD85281879A patent/DD239794A5/de not_active IP Right Cessation
- 1985-10-18 AU AU48856/85A patent/AU579413B2/en not_active Ceased
-
1987
- 1987-05-29 US US07/055,816 patent/US4762837A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN85107614A (zh) | 1986-07-16 |
CN1004274B (zh) | 1989-05-24 |
EP0180834B1 (de) | 1989-08-30 |
GR852529B (es) | 1986-02-19 |
CA1257261A (en) | 1989-07-11 |
ATE45949T1 (de) | 1989-09-15 |
US4681882A (en) | 1987-07-21 |
HUT39181A (en) | 1986-08-28 |
DK478585D0 (da) | 1985-10-18 |
EP0180834A1 (de) | 1986-05-14 |
DD239794A5 (de) | 1986-10-08 |
DE3438351A1 (de) | 1986-04-24 |
AU4885685A (en) | 1986-04-24 |
JPS61100582A (ja) | 1986-05-19 |
ES8605519A1 (es) | 1986-03-16 |
AU579413B2 (en) | 1988-11-24 |
DE3572663D1 (en) | 1989-10-05 |
ZA857989B (en) | 1986-06-25 |
DK478585A (da) | 1986-04-20 |
HU194227B (en) | 1988-01-28 |
US4762837A (en) | 1988-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO880182L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater. | |
ES548008A0 (es) | Procedimiento para preparar derivados de 4-alcoxi-pirido-(2,3-d)pirimidina | |
IT8324207A0 (it) | Carbossamido-derivati di 1,2,4-tiadiazolo [3,2-a] pirimidine e procedimento per la loro preparazione | |
RU93004860A (ru) | Гетероциклические соединения, способ их получения, использование и фармацевтическая композиция | |
NO171412C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater | |
NO871867D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske kondenserte tricykliske forbindelser. | |
NO874302D0 (no) | Fremgangsmaate for fremstilling av 4,5-dihydro- og 4,5,6,7-tetrahydro- pyrazolo (1,5-a)pyrimidiner. | |
SE8301004L (sv) | Pyridinforeningar | |
NO881768D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner. | |
MX161035A (es) | Procedimiento para la preparacion de imidazo(1,2-a)quinolinas | |
ES548007A0 (es) | Procedimiento para preparar derivados de 4-oxo-pirido(2,3-d)pirimidina | |
NO880663D0 (no) | Fremgangsmaate for aa oeke effektiviteten av in vitro vegetativ formering av poteter. | |
NO161563C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolo(1,5-a)pyridinderivater. | |
IT1193604B (it) | 1,3,4-tiadiazolo (3,2-a) pirimidine sostituite e procedimento per la loro preparazione | |
MX4817E (es) | Procedimiento para la preparacion de sales de imidazo-(1,2-a)-(1,5-a)piridina | |
NO167511C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater. | |
NO880127L (no) | Fremgangsmaate for fremstilling av (+-)-1,2-dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1,7-dicarboxylater. | |
NO170545C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 6,21-dimethyl-19-nor-pregna-diener | |
ES521739A0 (es) | Procedimiento para preparar derivados cicloalifaticos condensados de pirido(1,2-a)pirimidinas sustituidas. | |
ES549906A0 (es) | Procedimiento para la preparacion de derivados de 1,4-dihi- dropiridina | |
NO880492L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske triazolpyrimidinderivater. | |
ES532394A0 (es) | Procedimiento para la preparacion del citrato de la (-) vinburnina | |
ES534034A0 (es) | Procedimiento para la preparacion de derivados del 2, 4-difluorobifenilo | |
IT8421753A0 (it) | Agenti terapeutici per il trattamento di disturbi cardiaci edella circolazione, delle dislipidemie e delle deficienze delle prestazioni muscolari, procedimento per la loro preparazione e relative composizioni farmaceutiche. | |
IT8320672A0 (it) | Nuovi composti ad attivita'antineoplastica, procedimento per la loro preparazione e relative composizioni farmaceutiche. |